GOG 0213 Phase III randomized controled clinical trial of carboplatin and paclitaxel alone or in combination with bevacizumab followed by bevacizumab and secondary cytoreductive surgery in platinum sensitive recurent ovarian peritoneal primary and fallopi
Female Reproductive Cancer
Clinical trial of Carboplatin and Paclitaxel administered by IV, which is considered standard of care and Bevacizumab administered by IV and is investigational.
IRB Protocol #
REBECCA KISSANE at (720)848-7202 or REBECCA.KISSANE@UCDENVER.EDU
University of Colorado Hospital University of Colorado Hospital
Eligibility and Other Participant Information
What To Expect : A screening period to determine eligibility. A treatment period that can last up to nine months. A follow up period that will continue for the rest of your life. // Eligibility criteria include but are not limited to 18 years or older with ovarian, fallopian tube or peritoneal primary cancer.Eligibility criteria include but are not limited to 18 years or older with ovarian, fallopian tube or peritoneal primary cancer.